# Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

> **NCT01994460** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 429 (estimated)

## Conditions studied

- Pulmonary Tuberculosis Without Resistance to Rifampicin

## Interventions

- **DRUG:** Linezolid
- **DRUG:** Ethambutol

## Key facts

- **NCT ID:** NCT01994460
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 429 (ESTIMATED)
- **Last updated:** 2014-12-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01994460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01994460, "Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01994460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*